Literature DB >> 17211986

Cell cycle proteins in normal and chemically induced abnormal secondary palate development: a review.

Vamsidhara C Dhulipala1, Wade V Welshons, Chada S Reddy.   

Abstract

Cell cycle progression and thus proper cell number is essential for normal development of organs and organisms. Craniofacial tissues including the secondary palate are vulnerable to disruption of cell cycle progression and proliferation by many chemicals including mycotoxin, secalonic acid D (SAD), glucocorticoids, retinoic acid and 2,3,7,8-tetrachlorodibenzodioxin. Induction of cleft palate (CP) by SAD in mice occurs from a reduction in the size of developing palatal shelves. This is associated with an inhibition of proliferation of murine and human embryonic palatal mesenchymal (MEPM and HEPM) cells as well as a G1/S block of cell cycle. In murine embryonic palates and HEPM cells, SAD inhibited G1/S-phase-specific cyclin-dependent kinase (CDK)2 activity, reduced the level of cyclin E and increased the level of the CDK2 inhibitor, p21. These results, together with those from other laboratories, suggest that common cell cycle protein targets (biomarkers), relevant to the pathogenesis of CP by multiple chemical exposures, that can form the basis for the diagnosis and the development of preventive strategies, are likely to exist.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17211986     DOI: 10.1177/0960327106070848

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  11 in total

Review 1.  Palate morphogenesis: current understanding and future directions.

Authors:  Robert M Greene; M Michele Pisano
Journal:  Birth Defects Res C Embryo Today       Date:  2010-06

2.  TCDD disrupts hypural skeletogenesis during medaka embryonic development.

Authors:  Wu Dong; David E Hinton; Seth W Kullman
Journal:  Toxicol Sci       Date:  2011-10-20       Impact factor: 4.849

3.  Effect of EGF and FGF on the expansion properties of human umbilical cord mesenchymal cells.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Ali Mandegary; Seyed Noureddin Nematollahi-Mahani; Ehsan Janzamin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

4.  STIM1 plays an important role in TGF-β-induced suppression of breast cancer cell proliferation.

Authors:  Huanyi Cheng; Shiqiang Wang; Renqing Feng
Journal:  Oncotarget       Date:  2016-03-29

5.  Excessive All-Trans Retinoic Acid Inhibits Cell Proliferation Through Upregulated MicroRNA-4680-3p in Cultured Human Palate Cells.

Authors:  Hiroki Yoshioka; Sai Shankar Ramakrishnan; Junbo Shim; Akiko Suzuki; Junichi Iwata
Journal:  Front Cell Dev Biol       Date:  2021-01-28

6.  Sonic hedgehog pathway contributes to gastric cancer cell growth and proliferation.

Authors:  Jianhua Wan; Ji Zhou; Hailong Zhao; Mei Wang; Zhuanqin Wei; Hongyan Gao; Yongzhong Wang; Hongjuan Cui
Journal:  Biores Open Access       Date:  2014-04-01

Review 7.  Advances in the study of the structures and bioactivities of metabolites isolated from mangrove-derived fungi in the South China Sea.

Authors:  Xin Wang; Zhi-Gang Mao; Bing-Bing Song; Chun-Hua Chen; Wei-Wei Xiao; Bin Hu; Ji-Wen Wang; Xiao-Bing Jiang; Yong-Hong Zhu; Hai-Jun Wang
Journal:  Mar Drugs       Date:  2013-09-30       Impact factor: 5.118

8.  Dhcr7 Regulates Palatal Shelf Fusion through Regulation of Shh and Bmp2 Expression.

Authors:  Wen-lin Xiao; Dai-zun Zhang; Hong Xu; Cui-zhu Zhuang
Journal:  Biomed Res Int       Date:  2016-03-15       Impact factor: 3.411

9.  The role of VipAlbumin(®) as an immunostimulatory agent for controlling homeostasis and proliferation of lymphoid cells.

Authors:  Dinia Rizqi Dwijayanti; Muhammad Sasmito Djati; Muhaimin Rifa'I
Journal:  Cent Eur J Immunol       Date:  2016-03-24       Impact factor: 2.085

10.  lncRNA SOX2-OT regulates laryngeal cancer cell proliferation, migration and invasion and induces apoptosis by suppressing miR-654.

Authors:  Guang Li; Chunchen Pan; Jiaqiang Sun; Guanglun Wan; Jingwu Sun
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.